Table 3.
Demographic and clinical characteristics observed for single infection of different HRV species.
| HRV-A (N = 154) | HRV-B (N = 60) | HRV-C (N = 25) | χ2 | P | |
|---|---|---|---|---|---|
| Age, median (range) | 30 (14–87) | 29 (14–82) | 29(14–80) | ND | |
| Male | 70 (45.45%) | 26 (43.33%) | 12 (48%) | 0.17 | P > 0.05 |
| Symptoms and signs | |||||
| Rhinorrhea | 97 (62.99%) | 27 (45%) | 6 (24%) | 16.03 | P < 0.005 |
| Sneezing | 70 (45.45%) | 21 (35%) | 4 (16%) | 8.55 | P < 0.025 |
| Sore throat | 106 (68.83%) | 30 (50%) | 11 (44%) | 10.08 | P < 0.01 |
| Cough | 85 (55.19%) | 28 (46.67%) | 12 (48%) | 1.47 | P > 0.05 |
| Swelling of tonsils | 16 (10.39%) | 6 (10%) | 3 (12%) | 0.06 | P > 0.05 |
| Pharyngeal congestion | 149 (96.75%) | 57 (95%) | 23 (92%) | 1.35 | P > 0.05 |
| Expectoration | 40 (25.97%) | 11 (18.33%) | 7 (28%) | 1.58 | P > 0.05 |
| Abnormal breath sounds on auscultation | 1 (0.65%) | 3 (5%) | 2 (8%) | 6.78 | P < 0.05 |
| Chilliness | 107 (69.48%) | 51 (85%) | 16 (64%) | 6.35 | P < 0.05 |
| Rigors | 8 (5.19%) | 8 (13.33%) | 1 (4%) | 4.74 | P > 0.05 |
| Myalgia | 119 (77.27%) | 49 (81.67%) | 14 (56%) | 6.70 | P < 0.05 |
| Fever | |||||
| 38.1–39 °C | 137 (88.96%) | 49 (81.67%) | 19 (76%) | 4.07 | P > 0.05 |
| 39.1–41 °C | 17 (11.04%) | 11 (18.33%) | 6 (24%) | 4.07 | P > 0.05 |
| Headache | 114 (74.03%) | 47 (78.33%) | 20 (80%) | 0.71 | P > 0.05 |
| Preliminary clinical diagnosis | |||||
| Upper respiratory tract infection | 141 (91.56%) | 49 (81.67%) | 19 (76%) | 7.18 | P < 0.05 |
| Tonsillitis | 1 (0.65%) | 2 (3.33%) | 0 | ND | |
| Bronchitis | 1 (0.65%) | 0 | 0 | ND | |
| Pulmonary infection | 0 | 5 (8.33%) | 2 (8%) | ND | |
| Peripheral leukocyte count and classification | |||||
| NEUT%↑ | 76 (49.35%) | 29 (48.33%) | 14 (56%) | 0.45 | P > 0.05 |
| LYM%↓ | 107 (69.48%) | 40 (66.67%) | 19 (76%) | 0.72 | P > 0.05 |
ND: Not done. We could not do χ2 test between groups in these cases.
The P values that are of statistical significance are expressed as bold in Table.